We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy

    Vascular endothelial growth factor receptors (VEGFRs) are a family of receptor protein tyrosine kinases that play an important role in the regulation...

    Yun Liu, Yang Li, ... Lei Chen in Journal of Hematology & Oncology
    Article Open access 07 July 2022
  2. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway

    Purpose

    Triple-negative breast cancer (TNBC) features high aggressiveness, metastasis rate, drug resistance as well as poor prognosis. Osteopontin...

    Man Guo, Mengyue Liu, ... Hao Zhang in Journal of Cancer Research and Clinical Oncology
    Article Open access 25 March 2024
  3. Anticancer potential of four triterpenoids against NCI-60 human tumor cell lines

    Background

    The burden of cancer incidences and mortality is rapidly increasing worldwide resulting in an increased demand for new therapies. Secondary...

    Beatrice Njeri Irungu, Mary Nyangi, Fidelis Toloyi Ndombera in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 31 May 2024
  4. Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment

    Several studies have demonstrated the role of the oncogenic mutant p53 in promoting tumor progression; however, there is limited information on the...

    **ang Dong, Chunlu Li, ... Liu Cao in Oncogene
    Article Open access 11 November 2023
  5. Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells

    One of the most widespread forms of blood cancer is known as acute myeloid leukemia (AML) which has an incidence of 80% with poor prognosis. Although...

    Merve Şansaçar, Helin Sağır, Emel Başak Gencer Akçok in Medical Oncology
    Article 26 December 2023
  6. JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis

    The tumor-associated macrophage (TAM) is the most abundant group of immune cells in the tumor microenvironment (TME), which plays a critical role in...

    Siyuan Chen, Manni Wang, ... **awei Wei in Oncogene
    Article Open access 11 August 2023
  7. Drawbacks of immune checkpoint inhibition and rigorous management for immune-related adverse events along with a mathematical model to assess therapy success and optimum therapy duration and a strategy against tumor plasticity

    Purpose

    Immune checkpoint inhibition therapy (ICIT) is an emerging field in oncology especially opening new horizons to chemotherapy refractory...

    Article 19 April 2023
  8. CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL

    We recently reported that miR-146a is differentially expressed in ALK+ and ALK− anaplastic large cell lymphoma (ALCL). In this study, the downstream...

    Ivonne-Aidee Montes-Mojarro, Julia Steinhilber, ... Leticia Quintanilla-Martinez in Leukemia
    Article Open access 08 June 2022
  9. AGO4 suppresses tumor growth by modulating autophagy and apoptosis via enhancing TRIM21-mediated ubiquitination of GRP78 in a p53-independent manner

    Argonaute proteins, which consist of AGO1, AGO2, AGO3 and AGO4, are key players in microRNA-mediated gene silencing. So far, few non-microRNA related...

    Lin Wang, Da Li, ... Ningsheng Shao in Oncogene
    Article 12 November 2022
  10. HRCT1, negatively regulated by miR-124-3p, promotes tumor metastasis and the growth of gastric cancer by activating the ERBB2-MAPK pathway

    Background

    Gastric cancer is the fourth leading cause of cancer-related deaths worldwide. And patient outcomes are poor due to tumor relapse and...

    Feng Hou, Duan-Bo Shi, ... Peng Gao in Gastric Cancer
    Article 05 January 2023
  11. Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks

    Mortalin (encoded by HSPA9 ) is a mitochondrial chaperone often overexpressed in cancer through as-yet-unknown mechanisms. By searching different...

    Wen**g Chen, Young Shin Song, ... Jong-In Park in Oncogene
    Article 27 June 2024
  12. Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints

    RAC1 P29S is the third most prevalent hotspot mutation in sun-exposed melanoma. RAC1 alterations in cancer are correlated with poor prognosis,...

    Alexa C. Cannon, Konstantin Budagyan, ... Jonathan Chernoff in Oncogene
    Article 19 January 2024
  13. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment

    Cancer is a complex disease resulting from abnormal cell growth that is induced by a number of genetic and environmental factors. The tumor...

    Hongying Zhang, Yongliang Liu, ... Yangfu Jiang in Journal of Hematology & Oncology
    Article Open access 17 January 2024
  14. Salidroside suppresses cell growth and inflammatory response of fibroblast-like synoviocytes via inhibition of phosphoinositol-3 kinase/threonine kinase signaling in rheumatoid arthritis

    Background

    Salidroside (Sal) is a natural product commonly isolated from Rhodiola rosea L., which has been found to have numerous pharmacological...

    Ya**g Qin, Juan Su in Zeitschrift für Rheumatologie
    Article 18 October 2023
  15. Effect of ALA-PDT on inhibition of oral precancerous cell growth and its related mechanisms

    Backround

    Early treatment of oral precancerous lesions is considered as a key strategy for in oral carcinogenesis prevention. Increasing evidence has...

    Jian-qiu **, Qian Wang, ... Bo-wen Li in Lasers in Medical Science
    Article 07 July 2022
  16. Flotillin-1 palmitoylation is essential for its stability and subsequent tumor promoting capabilities

    Flotillin-1 contributes to invasion and metastasis in triple negative breast cancer (TNBC) and is modified post-translationally through...

    Bryan McClellan, Crystal N. Wilson, ... Linda deGraffenried in Oncogene
    Article 19 February 2024
  17. Roles of circRNAs in regulating the tumor microenvironment

    CircRNAs, a type of non-coding RNA widely present in eukaryotic cells, have emerged as a prominent focus in tumor research. However, the functions of...

    Tao Liu, Kaijun Long, ... **xian Ke in Medical Oncology
    Article Open access 11 October 2023
  18. Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody

    Regulatory T cells (Tregs) are known to facilitate tumor progression by suppressing CD8+ T cells within the tumor microenvironment (TME), thereby...

    Helge G. Roider, Sabine Hoff, ... Mátyás Gorjánácz in Clinical and Experimental Medicine
    Article Open access 10 June 2024
  19. HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression

    Despite the widespread use of the blockade of immune checkpoints, for a significant number of cancer patients, these therapies have proven...

    **aolei Li, **ao Su, ... Yufang Shi in Oncogene
    Article Open access 09 February 2021
Did you find what you were looking for? Share feedback.